李强：加大高质量科技供给和政策支持 着力推动生物医药产业提质升级

Core Insights - The Chinese government emphasizes the importance of advancing the biopharmaceutical industry to enhance public health and well-being, focusing on high-quality drug development and innovation [1][2] Group 1: Government Initiatives - The government aims to increase support for high-quality technological supply and policy backing to promote the biopharmaceutical industry's upgrade and innovation [1] - There is a call for collaboration in research focusing on new targets, compounds, and mechanisms to produce significant original results and cultivate high-end talent in life sciences [1] - The government recognizes the vast market potential for innovative drugs and encourages timely identification of high clinical value projects, enhancing tracking services for these innovations [1] Group 2: Industry Development - The biopharmaceutical sector is identified as a strategic emerging industry that directly impacts public health, necessitating original innovation and tackling key core technologies [2] - The integration of artificial intelligence is highlighted as a means to enhance various stages of drug development, clinical trials, diagnostics, and production [2] - There is a focus on optimizing the operational models of research platforms to facilitate the application of scientific and technological achievements in the biopharmaceutical field [2]